Foodborne Diseases Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Date : Mar 2018

Formats :
Report Code : PMR83649624

Category : Pharmaceutical and Healthcare
No Of Pages :
Global Foodborne diseases cover a broad spectrum of illnesses that are affecting the people worldwide. These diseases are due to the intake of food contaminated with harmful microorganisms or chemicals. The contamination occurs from any way either soil, water or air. The most common foodborne infections are caused by three bacteria campylobacter, salmonella, and E.coli and by a group of viruses called calicivirus. Clinical symptoms of foodborne diseases seen in gastro intestinal tract. Symptoms include vomiting, diarrhea, and abdominal pain. In some cases, such diseases can also have neurological, gynecological, immunological and other symptoms. Common foodborne diseases include botulism, salmonellosis, traveler’s diarrhoea, gastroenteritis, tapeworm infection and hepatitis A, among others. Global foodborne diseases treatment market is driven by the increasing incidence of foodborne diseases worldwide.



Global Foodborne Diseases Treatment Market


Increase in R&D investment, growing awareness about foodborne disease symptoms due to initiatives of government and nongovernment organizations such as WHO, and lack of hygiene conditions are boosting the foodborne diseases treatment market worldwide. However, the high cost of R&D investment for development of anti microbial and stringent, timeconsuming regulatory procedures are expected to hinder the foodborne diseases market.



Foodborne diseases treatment market has been segmented based on disease, drug class, and distribution channel



Based on drug class, foodborne diseases treatment market is segmented into

Antibiotics
Anti Diarrhea
Fluids and Electrolyte Replenishers
Vaccines
Others


Based on disease, foodborne diseases treatment is segmented into

Botulism
Traveler’s Diarrhea
Gastroenteritis
Toxoplasmosis
Others


Based on route of administration, foodborne diseases treatment market is segmented into

Parenteral
Oral
Others


Based on distribution channel, foodborne diseases treatment market is segmented into

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores


Foodborne diseases treatment market is expected to grow at significant CAGR during the forecast period. According to the findings of WHO – “Estimates of the global burden of foodborne diseases” 2015, almost 1 in every10 people fall ill yearly due to contaminated food consumption and 420,000 deaths occour as a result. Market players are adopting drug developments and collaborations as key market strategies.



Geographically Foodborne Diseases Treatment Market has been segmented into following regions viz. North America, Europe, AsiaPacific, Latin America, and Middle East & Africa. North America foodborne diseases treatment market is expected to grow at notable rates due to increase in the prevalence of foodborne diseases such as botulism and toxoplasmosis, and increase in R&D investment by companies on antibiotics and vaccines. Asia Pacific and Africa regions are projecting lucrative opportunity for foodborne diseases treatment market owing to increase in the incidence of foodborne diseases in these regions. According to WHO estimates 2015, Africa and South East Asia regions have the highest incidence and death rates, including children under the age of 5 years. Europe is expected to show significant growth rate owing to increase in R&D investment and healthcare spending.



Some of the market players in foodborne diseases treatment market are Bayer AG Germany, Johnson & Johnson Services Inc., U.S., Merck & Co., Inc. U.S., GlaxoSmithKline plc U.K, Novartis AG Switzerland, XOMA Corporation U.S., AlphaVax, Inc. U.S., Molecular Targeting Technologies, Inc. U.S., and Morphotek Inc. U.S. to name a few



In 2015, January, Valneva SE, entered a purchase and sale with Crucell Holland B.V. in order to acquire Crucell Sweden AB and privileges and licenses of dukoral vaccine to treat cholera and traveler’s diarrhea
1. Executive Summary
2. Global Foodborne Disease Treatment Market Introduction
2.1. Global Foodborne Disease Treatment Market – Taxonomy
2.2. Global Foodborne Disease Treatment Market –Definitions
2.2.1. Drug Class
2.2.2. Disease
2.2.3. Route of Administration
2.2.4. Distribution Channel
3. Global Foodborne Disease Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Foodborne Disease Treatment Market Dynamics – Factors Impact Analysis
3.6. Global Foodborne Disease Treatment Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.6.3. Japan
3.7. Global Foodborne Disease Treatment Market – Drug Class Pipeline Analysis
4. Global Foodborne Disease Treatment Market Analysis, 2013 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
4.2. YearoverYear YoY Growth Analysis %
4.3. Market Oppurtunity Analysis
5. Global Foodborne Disease Treatment Market, By Drug Class, 2013 2017 and Forecast, 2018 2024
5.1. Antibiotics
5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.1.3. Market Opportunity Analysis
5.2. Anti Diarrhea
5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.2.3. Market Opportunity Analysis
5.3. Fluids and Electrolyte Replenishers
5.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.3.3. Market Opportunity Analysis
5.4. Vaccines
5.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.5.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.5.3. Market Opportunity Analysis
6. Global Foodborne Disease Treatment Market Forecast, By Disease, 2013 2017 and Forecast, 2018 2024
6.1. Botulism
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.1.3. Market Opportunity Analysis
6.2. Traveler’s Diarrhea
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.2.3. Market Opportunity Analysis
6.3. Gastroenteritis
6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.3.3. Market Opportunity Analysis
6.4. Toxoplasmosis
6.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.5.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.5.3. Market Opportunity Analysis
7. Global Foodborne Disease Treatment Market Forecast, By Route of Administration, 2013 2017 and Forecast, 2018 2024
7.1. Oral
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.1.3. Market Opportunity Analysis
7.2. Parenteral
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.3.3. Market Opportunity Analysis
8. Global Foodborne Disease Treatment Market Forecast, By Distribution Channel, 2013 2017 and Forecast, 2018 2024
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.1.3. Market Opportunity Analysis
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.2.3. Market Opportunity Analysis
8.3. Online Pharmacies
8.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.3.3. Market Opportunity Analysis
8.4. Drug Stores
8.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.4.3. Market Opportunity Analysis
9. Global Foodborne Disease Treatment Market Forecast, By Region, 2013 2017 and Forecast, 2018 2024
9.1. North America
9.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
9.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
9.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
9.2.3. Market Opportunity Analysis
9.3. AsiaPacific
9.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
9.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
9.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
9.5.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
9.5.3. Market Opportunity Analysis
9.6. Global Foodborne Disease Treatment Market Opportunity Analysis Index, By Drug Class, By Disease, By Route of Administration, By Distribution Channel, and Region, 2018 – 2024
10. North America Foodborne Disease Treatment Market Analysis, 2013 2017 and Forecast, 2018 2024
10.1. Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
10.1.1. Antibiotics
10.1.2. Anti Diarrhea
10.1.3. Fluids and Electrolyte Replenishers
10.1.4. Vaccines
10.1.5. Others
10.2. Disease Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
10.2.1. Botulism
10.2.2. Traveler’s Diarrhea
10.2.3. Gastroenteritis
10.2.4. Toxoplasmosis
10.2.5. Others
10.3. Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
10.3.1. Oral
10.3.2. Parenteral
10.3.3. Others
10.4. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.4.4. Drug Stores
10.5. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
10.5.1. U.S.
10.5.2. Canada
10.6. North America Foodborne Disease Treatment Market Opportunity Analysis Index, By Drug Class, By Disease, By Route of Administration, By Distribution Channel, and Country, 2018 – 2024
10.7. North America Foodborne Disease Treatment Market Dynamics – Trends
11. Europe Foodborne Disease Treatment Market Analysis, 2013 2017 and Forecast, 2018 2024
11.1. Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
11.1.1. Antibiotics
11.1.2. Anti Diarrhea
11.1.3. Fluids and Electrolyte Replenishers
11.1.4. Vaccines
11.1.5. Others
11.2. Disease Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
11.2.1. Botulism
11.2.2. Traveler’s Diarrhea
11.2.3. Gastroenteritis
11.2.4. Toxoplasmosis
11.2.5. Others
11.3. Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
11.3.1. Oral
11.3.2. Parenteral
11.3.3. Others
11.4. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.4.4. Drug Stores
11.5. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Foodborne Disease Treatment Market Opportunity Analysis Index, By Drug Class, By Disease, By Route of Administration, By Distribution Channel, and Country, 2018 – 2024
11.7. Europe Foodborne Disease Treatment Market Dynamics – Trends
12. AsiaPacific Foodborne Disease Treatment Market Analysis, 2013 2017 and Forecast, 2018 2024
12.1. Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
12.1.1. Antibiotics
12.1.2. Anti Diarrhea
12.1.3. Fluids and Electrolyte Replenishers
12.1.4. Vaccines
12.1.5. Others
12.2. Disease Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
12.2.1. Botulism
12.2.2. Traveler’s Diarrhea
12.2.3. Gastroenteritis
12.2.4. Toxoplasmosis
12.2.5. Others
12.3. Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
12.3.1. Oral
12.3.2. Parenteral
12.3.3. Others
12.4. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.4.4. Drug Stores
12.5. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn,
YoY Growth %, and Market Share %
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of AsiaPacific
12.6. AsiaPacific Foodborne Disease Treatment Market Opportunity Analysis Index, By Drug Class, By Disease, By Route of Administration, By Distribution Channel, and Country, 2018 – 2024
12.7. AsiaPacific Foodborne Disease Treatment Market Dynamics – Trends
13. Latin America Foodborne Disease Treatment Market Analysis, 2013 2017 and Forecast, 2018 2024
13.1. Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
13.1.1. Antibiotics
13.1.2. Anti Diarrhea
13.1.3. Fluids and Electrolyte Replenishers
13.1.4. Vaccines
13.1.5. Others
13.2. Disease Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
13.2.1. Botulism
13.2.2. Traveler’s Diarrhea
13.2.3. Gastroenteritis
13.2.4. Toxoplasmosis
13.2.5. Others
13.3. Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
13.3.1. Oral
13.3.2. Parenteral
13.3.3. Others
13.4. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.4.4. Drug Stores
13.5. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Venezuela
13.5.5. Rest of Latin America
13.6. Latin America Foodborne Disease Treatment Market Opportunity Analysis Index, By Drug Class, By Disease, By Route of Administration, By Distribution Channel, and Country, 2018 – 2024
13.7. Latin America Foodborne Disease Treatment Market Dynamics – Trends
14. Middle East and Africa Foodborne Disease Treatment Market Analysis, 2013 2017 and Forecast, 2018 2024
14.1. Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
14.1.1. Antibiotics
14.1.2. Anti Diarrhea
14.1.3. Fluids and Electrolyte Replenishers
14.1.4. Vaccines
14.1.5. Others
14.2. Disease Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
14.2.1. Botulism
14.2.2. Traveler’s Diarrhea
14.2.3. Gastroenteritis
14.2.4. Toxoplasmosis
14.2.5. Others
14.3. Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
14.3.1. Oral
14.3.2. Parenteral
14.3.3. Others
14.4. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.4.4. Drug Stores
14.5. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
14.5.1. Gulf Cooperation Council GCC Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Foodborne Disease Treatment Market Opportunity Analysis Index, By Drug Class, By Disease, By Route of Administration, By Distribution Channel, and Country, 2018 – 2024
14.7. MEA Foodborne Disease Treatment Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles Introduction, Financial Analysis, Drug Class & Service Offerings, Key Developments, Strategies, and SWOT Analysis
15.2.1. GE Healthcare U.S.
15.2.2. Hitachi, Ltd. Hitachi Medical Corporation Japan
15.2.3. Hologic, Inc. U.S.
15.2.4. Koninklijke Philips N.V. Philips Healthcare Netherlands
15.2.5. Siemens AG Germany
15.2.6. Carestream Health U.S.
15.2.7. Toshiba Corporation Japan
15.2.8. Shimadzu Corporation Japan
15.2.9. Fujifilm Holdings Corporation Japan
15.2.10. Esaote SpA Italy
16. Research Methodology
Key Assumptions and Acronyms
  Purchase Options for Report

Need More information

Call us :
USA : +1 7162260907
UK : +44 7441952057
....
sales@planetmarketreports.com

Why to PMR

PMR Market Research

Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.

  • Industrial ...
  • Business ....
  • Consumer ....
  • Peer ....